POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION

Show other versions (1)

<p><strong>Aim.</strong> To study effect of the bone metabolism modulator strontium ranelate on bone mineral density (BMD) and to evaluate it pleiotropic effects on cardiovascular remodeling in women with postmenopausal osteoporosis (PO) and a arterial hypertension (HT).</p>&...

Full description

Bibliographic Details
Main Authors:	N. J. Hozjainova, V. M. Tsareva, T. V. Brook, M. S. Bezaltynnyh
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	стронция ранелат постменопаузальный остеопороз артериальная гипертония сердечно-сосудистое ремоделирование
Online Access:	http://www.rpcardio.ru/jour/article/view/614

Similar Items

PLEIOTROPIC EFFECTS OF THE BONE METABOLISM MODULATOR - STRONTIUM RANELATE IN TREATMENT OF WOMEN WITH THE POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION.
by: N. Yu. Khozyainova, et al.
Published: (2010-04-01)

SNIZhENIE MINERAL'NOY PLOTNOSTI KOSTNOY TKANI -DOPOLNITEL'NYY KRITERIY STRATIFIKATsII SERDEChNOSOSUDISTOGO RISKA U ZhENShchIN POSTMENOPAUZAL'NOGO PERIODA S ARTERIAL'NOY GIPERTONIEY
by: N Yu Khozyainova, et al.
Published: (2010-12-01)

POSSIBILITIES AND PROSPECTS OF DOUBLE EFFECT DRUGS APPLICATION FOR SYSTEMIC OSTEOPOROSIS PHARMACOTHERAPY OF PATIENTS WITH BONE FRACTURES
by: A. Y. Kochish, et al.
Published: (2012-06-01)

PHARMACOLOGICAL CORRECTION OF CEREBRAL BLOOD FLOW DISTURBANCES IN WOMEN WITH ARTERIAL HYPERTENSION IN POSTMENOPAUSE
by: V. V. Yakusevich, et al.
Published: (2015-12-01)

FRACTURE HEALING AND ANTIOSTEOPOROTIC TREATMENT
by: George P. Lyritis
Published: (2012-12-01)

POSSIBILITY OF BONE METABOLISM MODULATOR (STRONTIUM RANELATE) USAGE FOR THE TREATMENT OF WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION
by: N. J. Hozjainova, et al.
Published: (2016-01-01)

THE INFLUENCE OF AWARENESS OF PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS ABOUT THE MAGNITUDE OF THE FRAX 10-YEAR ABSOLUTE RISK OF FRACTURE ON THE DECISION TO START AND THE ADHERENCE TO ANTIOSTEOPOROTIC TREATMENT (INTERIM RESULTS OF «CRYSTAL» STUDY)
by: O M Lesnyak, et al.
Published: (2014-12-01)

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

RATsIONAL'NYY VYBOR FARMAKOTERAPII POSTMENOPAUZAL'NOGO OSTEOPOROZA.EFFEKTIVNOST' I BEZOPASNOST' BONVIVY: OBZOR ZA VOSEM' LET PRIMENENIYa
by: Zh E BELAYa, et al.
Published: (2013-12-01)

SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY
by: A. V. Rudenko, et al.
Published: (2015-09-01)

Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial
by: Cyrus Cooper, et al.
Published: (2013-12-01)

Assotsiatsiya polimorfnogo varianta (CA)ngena kal'tsitonina (CALCA) s riskom razvitiyapostmenopauzal'nogo osteoporoza i urovnemkal'tsitonina v syvorotke krovi u russkikh zhenshchinVolgo-Ural'skogo regiona Rossii
by: L. I. Selezneva, et al.
Published: (2008-12-01)

Влияние фозиноприла, амлодипина и метопролола на обратное развитие процессов ремоделирования органов-мишеней у больных артериальной гипертонией
Published: (2018-06-01)

EFFECT OF ZOLEDRONIC AND IBANDRONIC ACIDS ON BONE METABOLISM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
by: O V Yakushevskaya, et al.
Published: (2012-08-01)

CORRELATION OF STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE WITH AMBULATORY BLOOD PRESSURE MONITORING DATA IN PATIENTS WITH ESSENTIAL HYPERTENSION
by: O. M. Khromtsova, et al.
Published: (2016-01-01)

THE STATE OF ARTERIAL HYPERTENSION DIAGNOSTICS AND TREATMENT, ACCORDING TO THE RESULTS OF THE POLL AMONG PHYSICIANS OF VOLGOGRAD AND VOLGOGRAD REGION
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Insulin-like growth factor-1 and myocardial remodeling in female patients with arterial hypertension and metabolic syndrome
by: A. N. Zakirova, et al.
Published: (2015-11-01)

FEATURES OF LEFT VENTRICULAR REMODELING OPTIONS IN MALE MIGRANTS OF THE FAR NORTH WITH ARTERIAL HYPERTENSION, DIFFERENT CONSTITUTIONAL TYPES
by: Roman Anatolyevich Yaskevich, et al.
Published: (2020-12-01)

REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS
by: M. N. Mamedov, et al.
Published: (2015-12-01)

Rossiyskoe mnogotsentrovoe issledovanie FAGOT (farmakoekonomicheskaya otsenka ispol'zovaniya ingibitorov angiotenzinprevrashchayushchego fermenta v ambulatornom lechenii bol'nykh arterial'noy gipertoniey oslozhnennogo techeniya)
by: I E Chazova
Published: (2004-03-01)

Ot idei k klinicheskoy praktike: pervye rezul'taty Rossiyskogo natsional'nogo issledovaniya optimal'nogo snizheniya arterial'nogo davleniya (ROSA)
by: I E Chazova, et al.
Published: (2004-06-01)

ORIGINAL ARTICLES CLINICAL AND PROGNOSTIC SIGNIFICANCE OF MOLECULAR GENETIC FACTORS IN POSTMENOPAUSAL OSTEOPOROSIS
by: S V Yureneva, et al.
Published: (2015-12-01)

Pathogenetic mechanisms of postmenopausal osteoporosis formation and their relationship with cardiovascular pathology
by: G. V. Poryadin, et al.
Published: (2022-04-01)

КОНСТИТУЦИОНАЛЬНЫЕ ОСОБЕННОСТИ ВАРИАНТОВ РЕМОДЕЛИРОВАНИЯ ЛЕВОГО ЖЕЛУДОЧКА У ЖЕНЩИН С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ РАНЕЕ ПРОЖИВАВШИХ В УСЛОВИЯХ ЗАПОЛЯРЬЯ
by: Roman A. Yaskevich, et al.
Published: (2021-08-01)

KAChESTVO LEChENIYa POSTMENOPAUZAL'NOGO OSTEOPOROZA V MOSKOVSKOY OBLASTI
by: L. A. MARChENKOVA, et al.
Published: (2011-12-01)

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii
by: G Mancia, et al.
Published: (2013-12-01)

ANALYSIS OF THE INCIDENCE AND STRUCTURE OF THE CARDIOVASCULAR SYSTEM DISEASES IN THE FAR NORTH MIGRANTS OVER THE PERIOD OF READAPTATION TO THE NEW CLIMATIC CONDITIONS
by: Roman Anatolyevich Yaskevich, et al.
Published: (2017-12-01)

Rekomendatsii ESH/ESC 2013 g. po lecheniyu arterial'noy gipertonii
by: G Mancia, et al.
Published: (2013-09-01)

The influence of surgical menopause oncardiovascular and osteoporosis risk factors(clinical observations)
by: E. Yu. Maychuk, et al.
Published: (2011-04-01)

Clinical and laboratory comparison in postmenopausal osteoporosis with normal and enhanced function of the parathyroid glands
by: K. A. Saveleva, et al.
Published: (2015-06-01)

Патогенез артериальной гипертензии (Лекция)
by: Дмитрий Игоревич Василевский, et al.
Published: (2020-12-01)

Features of clinical-functional parameters of the heart, vessels and microcirculation in patients with arterial hypertension in the combination to chronic obstructive pulmonary diseases
by: I. S. Shpagin, et al.
Published: (2010-12-01)

OTsENKA VLIYaNIYa PERENESENNYKh PERELOMOV LUChEVOYKOSTI NA KAChESTVO ZhIZNI ZhITEL'NITs EKATERINBURGA,STRADAYuShchIKh POSTMENOPAUZAL'NYM OSTEPOROZOM
by: A A POPOV, et al.
Published: (2007-12-01)

Korotkiy put' k zavetnoy tseli – ko-renitek dlya patsienta s AG
by: I E Chazova, et al.
Published: (2005-06-01)

Preparat kal'tsitonina v lechenii i profilaktike postmenopauzal'nogo osteoporoza (klinicheskaya lektsiya)
by: D B Yureneva
Published: (2004-08-01)

Otsenka effektivnosti moeksiprila u bol'nykh myagkoy i umerennoy arterial'noy gipertoniey s gipertrofiey miokarda levogo zheludochka (issledovanie ENIGMA)
by: Yu N Belenkov, et al.
Published: (2005-03-01)

RESISTANT ARTERIAL HYPERTENSION: IS THE CONSENSUS BETWEEN CONSERVATIVE AND INTERVENTIONAL THERAPY POSSIBLE?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

CORRECTION OF PSYCHO-AUTONOMIC DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION DURING POSTMENOPAUSAL PERIOD
by: G. G. Semenkova, et al.
Published: (2016-01-01)

PATOGENETIChESKIE OSNOVY RAZVITIYa OSTROY FAZY OTVETA NA VNUTRIVENNOE VVEDENIE AZOTSODERZhAShchIKh BISFOSFONATOV
by: O V YaKUShEVSKAYa, et al.
Published: (2014-12-01)